文章詳目資料
藥物食品檢驗局調查研究年報
加入收藏
下載文章
中文摘要
爲瞭解市售輸入凝血因子血液製劑之品質，於民國八十四年七月至八十五 年六月間，由台灣地區該類藥品代理商處直接抽購檢體計10件，含第八凝血 因子（Factor VIII) 9件及第九凝血因子（Factor IX complex) 1件。分别依原廠之 方法做適當修正測定其凝血時間，並計算其相對效價。結果第八凝血因子及第 九凝血因子效價均符合我國「生物製劑檢驗基準」之規定。
英文摘要
In order to evaluate the quality of imported antihemophilic factor VIII and factor IX in Taiwan, potency tests were conducted on nine samples of factor VIII and one sample of factor IX purchased randomly from the Taiwan representative of 10 overseas manufac- turers between July 1995 and June 1996. All these samples were assayed according to the analytical protocols provided by the manufacture’s with some modifications. All the samples met the Minimum Requirements of Biological Standard.